Safety Rates Drug Report: ATORVASTATIN CALCIUM. Product substitution issue adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

The Safety Rates Drug Report

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: ATORVASTATIN CALCIUM. Injury: Product substitution issue Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 9 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
117682712	ATORVASTATIN CALCIUM.	Product substitution issue	APOTEX	0.00	F	58 KG	20160725	US
124180112	ATORVASTATIN CALCIUM.	Product substitution issue	APOTEX	0.00	M	0	20160725	US
125875211	ATORVASTATIN CALCIUM.	Product substitution issue	APOTEX	0.00	F	77 KG	20160725	US
125876251	ATORVASTATIN CALCIUM.	Product substitution issue	APOTEX	0.00		0	20160725	US
125876921	ATORVASTATIN CALCIUM.	Product substitution issue	APOTEX	0.00	M	0	20160725	US
125896671	ATORVASTATIN CALCIUM.	Product substitution issue	APOTEX	75.27 YR	M	78 KG	20160725	US
125897121	ATORVASTATIN CALCIUM.	Product substitution issue	APOTEX	0.00	F	0	20160725	US
125898311	ATORVASTATIN CALCIUM.	Product substitution issue	APOTEX	0.00	M	0	20160725	US
126154881	ATORVASTATIN CALCIUM.	Product substitution issue	APOTEX	0.00	F	0	20160802	US

|< 1/2 << Previous Page Page 1

Total Records: 9 Number of Pages: 1

Execution Time: 0.22233319282532 seconds (ucode:4996754). Developed by: James D. Barger